No tax




Security policy (edit with Customer reassurance module)


Delivery policy (edit with Customer reassurance module)


Return policy (edit with Customer reassurance module)

Active ingredient

Irunin vaginal tablets white or almost white in the form of a ring
1 pill contains itraconazole 200 mg;
Excipients: lactose (milk sugar); potato starch; sodium lauryl sulfate; Povidone (polyvinylpyrrolidone); talc; Magnesium stearate.

antifungal agent


Itraconazole is a triazole derivative. Irunin inhibits (disrupts) the synthesis of ergosterol, which is an important component of the cell membrane of fungi, which causes the antifungal effect of the drug.
Irunin it is active against dermatophytes (Trichophyton spp., Microsporum spp., Epidermophyton floccosum), and Candida spp. (including Candida albicans, Candida glabrata, Candida krusei), mold fungi (Cryptococcus neoformans, Aspergillus spp., Histoplasma spp., Paracoccidioides brasiliensis, Sporothrix schenckii, Fonsecae spp., Cladosporium spp. spp. shepp, spp. spp. spp. spp. pepp.

Indications and usage

Irunin vaginal pills are indicated for the local treatment of vulvovaginal candidiasis (incl. Recurrent).


Hypersensitivity to the components of the drug, pregnancy (I term)

Women of childbearing age, taking Irunin, you must use adequate methods of contraception throughout the course of treatment until the first menstruation after its completion.
Pregnant women in the II and III trimester Irunin should be prescribed only if the expected benefit to the woman outweighs the potential risk to the fetus. Since a small amount of itraconazole is excreted in breast milk, the expected benefits of taking itraconazole must be compared with the risk to the baby when breastfeeding. In case of doubt, it is necessary to resolve the issue of termination of breastfeeding.

Local reactions: itching, burning sensation in the vagina, skin rash in the external genital organs, which do not require discontinuation of the drug.

Special notes

To prevent reinfection, simultaneous treatment of sexual partners is necessary.
During the period of treatment is recommended to refrain from sexual contact.
To prevent reinfection should follow the rules of hygiene.
If the clinical signs of infection persist after completion of treatment, a microbiological examination should be repeated to confirm the diagnosis.
If an allergic reaction occurs, treatment should be discontinued. If necessary, the drug can be removed by washing the vagina with boiled water.
The drug does not affect the performance of potentially hazardous activities that require concentration of attention and quick psychomotor reactions (driving and other).

In a dry, dark place, at a temperature not higher than 25 ° C.
Shelf life - 2 years.


35 Items